anda

(redirected from abbreviated new drug application)
Also found in: Medical, Acronyms.

anda

The hemispherical dome of a stupa.
McGraw-Hill Dictionary of Architecture and Construction. Copyright © 2003 by McGraw-Hill Companies, Inc.
References in periodicals archive ?
Pharmaceutical marketing company Breckenridge Pharmaceutical Inc revealed on Tuesday the receipt of the US Food and Drug Administration final approval for its Abbreviated New Drug Application for Clobazam Tablets, CIV in 10 mg and 20 mg tablets.
In a paragraph IV notice letter, also addressed to Pronova BioPharma's US marketing partner GlaxoSmithKline Inc (LON:GSK), Sandoz said it had filed an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) to sell a generic version of Lovaza, used for post-heart attack treatment.
Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Minoxidil Foam, a generic version of Men's Rogaine Foam.
Under the current regulation, as a drug's original patent runs out, drug companies can file a new, amended, or supplemental NDA or an abbreviated new drug application (ANDA) in an effort to continue the drug's patent protection beyond what the original law intended.
International pharmaceutical and health care company, F H Faulding & Co Limited (Faulding), Adelaide, South Australia, has announced that its Faulding Pharmaceuticals division has received final approval from the Food and Drug Administration (FDA) in the United States for its abbreviated new drug application (ANDA) for enalaprilat injection, following the expiry of the paediatric exclusivity period on 22 August 2000.
Food and Drug Administration for the company's Abbreviated New Drug Application ("ANDA") for Hydrocodone Bitartrate and Homatropine Methylbromide Syrup, 5 mg and 1.5 mg, respectively, /5 mL.
Food and Drug Administration through the Abbreviated New Drug Application pathway.
M2 EQUITYBITES-July 6, 2018-US FDA approves Elite Pharmaceuticals' abbreviated new drug application for Percocet
M2 PHARMA-July 6, 2018-US FDA approves Elite Pharmaceuticals' abbreviated new drug application for Percocet
USA, a subsidiary of Glenmark Pharmaceuticals Ltd., says it has received approval from the Food and Drug Administration of the Abbreviated New Drug Application (ANDA) for its generic levonorgestrel and ethinyl estradiol tablets USP (0.09 mg/0.02 mg), which are the therapeutic equivalent of Wyeth's Lybrel, a combination of female hormones that prevents ovulation.

Full browser ?